WuXi Biologics (Cayman) Inc. (FRA:1FW2)
Germany · Delayed Price · Currency is EUR 3.701
+0.081 (2.24%)
At close: Dec 19, 2025
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of €15.46 billion as of December 19, 2025. Its market cap has increased by 111.03% in one year.
Market Cap
15.46B
Enterprise Value
15.06B
Revenue
2.38B
Ranking
n/a
PE Ratio
31.00
Stock Price
€3.70
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 3.67B to 15.46B, an increase of 321.89%. That is a compound annual growth rate of 18.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 15.46B | 72.47% |
| Dec 31, 2024 | 8.97B | -38.06% |
| Dec 29, 2023 | 14.48B | -52.26% |
| Dec 30, 2022 | 30.32B | -31.22% |
| Dec 31, 2021 | 44.08B | -0.43% |
| Dec 31, 2020 | 44.28B | 203.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |